Fighting with ‘Superfactory’ is one of the most important health challenges of this century, and the strategies to do so are very different. Researchers of Plas Cabrera Physics (IQF-CSIC) And the notrah Dame of the United States – has identified one from the University of Indiana: A mixture of the ability to block the ability Bacteria Staphylococcus aureus To retain antibiotics.
This pathogen is considered a ‘super bacteria’ because it allows the process of many antibiotics due to its ability to develop its mechanisms, which is called an event Tolerance It prevents the treatment of infections that cause, some of which are possible for death.
In particular, the strains of the anti -antibiotic germ Areius .
Currently, opposition Staphylococcus aureus For many antibiotics, especially those who are called β-lactams such as penicillin, the treatment is significantly complicated. Increase death and health costs Partners
But this research was published in the last issue of the magazine Natural chemistryIt provides a new way to allow these antibiotics to be used, which can be effective for a long time against bacteria, which cannot be used against the anti -inflammatory strains of this pathogen that causes skin conditions to pneumonia and septichemia.
It is important that antibiotics will act against it and its strategy It has already worked in miceNow it should be rehearsed in humans. Researchers believe that this new attack will continue, because it is about the restoration of existing antibiotics without the need to create new ones. This is an important step in the race that has been fought for decades against Superfacteria.
